These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37273749)

  • 41. Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response.
    Wilkinson R; Hines L; Holland A; Mandal S; Phipps E
    Harm Reduct J; 2020 Dec; 17(1):95. PubMed ID: 33261636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tuberculosis and COVID-19 Related Stigma: Portuguese Patients Experiences.
    Alfaiate A; Rodrigues R; Aguiar A; Duarte R
    Tuberc Respir Dis (Seoul); 2023 Jul; 86(3):216-225. PubMed ID: 36999371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential impacts of COVID-19 and associated responses on the health, social well-being and food security of users of supportive social and health programs during the COVID-19 pandemic: A qualitative study.
    Mejia-Lancheros C; Alfayumi-Zeadna S; Lachaud J; O'Campo P; Gogosis E; Da Silva G; Stergiopoulos V; Hwang SW; Thulien N
    Health Soc Care Community; 2022 Nov; 30(6):e4332-e4344. PubMed ID: 35524402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Healthcare stigma and HIV risk among rural people who inject drugs.
    Surratt HL; Otachi JK; McLouth CJ; Vundi N
    Drug Alcohol Depend; 2021 Sep; 226():108878. PubMed ID: 34214880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
    Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
    Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies.
    Henderson R; McInnes A; Mackey L; Bruised Head M; Crowshoe L; Hann J; Hayward J; Holroyd BR; Lang E; Larson B; Leonard AJ; Persaud S; Raghavji K; Sarin C; Virani H; Wadsworth IW; Whitman S; McLane P
    BMC Public Health; 2021 Jul; 21(1):1471. PubMed ID: 34320954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of peer support on testing, linkage to and engagement in HIV care for people who inject drugs in Indonesia: qualitative perspectives from a community-led study.
    Iryawan AR; Stoicescu C; Sjahrial F; Nio K; Dominich A
    Harm Reduct J; 2022 Feb; 19(1):16. PubMed ID: 35148776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stigma and Discrimination (SAD) at the Time of the SARS-CoV-2 Pandemic.
    Baldassarre A; Giorgi G; Alessio F; Lulli LG; Arcangeli G; Mucci N
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32878180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 'Why would we not want to keep everybody safe?' The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland.
    Parkes T; Price T; Foster R; Trayner KMA; Sumnall HR; Livingston W; Perkins A; Cairns B; Dumbrell J; Nicholls J
    Harm Reduct J; 2022 Aug; 19(1):99. PubMed ID: 36038919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: A qualitative study.
    Dunleavy K; Hope V; Roy K; Taylor A
    Int J Drug Policy; 2019 Mar; 65():65-72. PubMed ID: 30665085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain.
    Shirley-Beavan S; Roig A; Burke-Shyne N; Daniels C; Csak R
    Harm Reduct J; 2020 Oct; 17(1):78. PubMed ID: 33076931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Weight stigma in the COVID-19 pandemic: a scoping review.
    de Macêdo PFC; Nepomuceno CMM; Dos Santos NS; Queiroz VAO; Pereira EM; Leal LDC; Santos LADS; Nascimento LF; Martins PC; de Santana MLP
    J Eat Disord; 2022 Mar; 10(1):44. PubMed ID: 35351201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile.
    Scheim AI; Sniderman R; Wang R; Bouck Z; McLean E; Mason K; Bardwell G; Mitra S; Greenwald ZR; Thavorn K; Garber G; Baral SD; Rourke SB; Werb D
    J Urban Health; 2021 Aug; 98(4):538-550. PubMed ID: 34181179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
    BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions.
    Bouck Z; Scheim AI; Gomes T; Ling V; Caudarella A; Werb D
    Int J Drug Policy; 2022 Jun; 104():103680. PubMed ID: 35447476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Injecting Alone: Practices and Preferences among People Who Inject Drugs in New York City.
    Riback L; Pérez-Correa AE; Ghiroli MM; López-Castro T; Fox AD
    Subst Use Misuse; 2022; 57(13):1988-1996. PubMed ID: 36151968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intersecting Stigmas among HIV-Positive People Who Inject Drugs in Vietnam.
    Do M; Ho HT; Dinh HT; Le HH; Truong TQ; Dang TV; Nguyen DD; Andrinopoulos K
    Health Serv Insights; 2021; 14():11786329211013552. PubMed ID: 33994794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives.
    May T; Dawes J; Fancourt D; Burton A
    Int J Drug Policy; 2022 Aug; 106():103752. PubMed ID: 35653821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential experiences of Mexican policing by people who inject drugs residing in Tijuana and San Diego.
    Wood EF; Werb D; Beletsky L; Rangel G; Cuevas Mota J; Garfein RS; Strathdee SA; Wagner KD
    Int J Drug Policy; 2017 Mar; 41():132-139. PubMed ID: 28111221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Health service utilization and experiences of stigma amongst people who inject drugs in Melbourne, Australia.
    Djordjevic F; Ryan K; Gunn J; Brener L; O'Keefe D; Draper B; Schroeder S; Gold J; Treloar C; Broady T; Dietze P; Hellard M; Pedrana A
    J Viral Hepat; 2021 Dec; 28(12):1738-1743. PubMed ID: 34510655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.